Grants for Businesses in EU

Expected Impact: The action under this topic is expected to achieve the following impacts and contribute to the following EU policies/initiatives: deliver innovative, early technology solutions that contribute to addressing strategic unmet public health needs across multiple therapy areas to improve prevention, early diagnosis, and treatment; leverage the unique network and scale of IHI JU members to create a pipeline to support innovative startups in the health industry, fully integrated into European initiatives in support of start-ups and entrepreneurship; drive early cross-sector health R&D and innovation to strengthen the European healthcare industry’s global competitiveness, contributing to the EU Industrial Strategy and Pharmaceutical Strategy objectives; create a sustainable network of European healthcare incubators to guide and support highly talented and innovative early-stage companies; harness digital health and data-sharing technologies (e.g., AI and big data) to enable interoperable health solutions, contributing to the European Health Data Space (EHDS) and improved evidence based care;- the action should generate a portfolio of early‑stage companies that have…

Expected Outcome: The action should establish a supply chain data platform, as a digital twin of the semiconductor supply chain, which should: • Gather secure, anonymized data shared by companies, coming from both upstream and downstream industries. • Possibly make use of an existing digital reference14 of the semiconductor supply chain (based on semantic web technologies). • Be managed by a trusted intermediary and hosted on a trusted data sharing infrastructure (potentially leveraging secure Multi-Party Computation). • Provide access to each participating company (providing its data) to its own data and aggregate anonymised data. The action should support the data gathering from the companies involved. The action should support a global mapping of the semiconductor value chain, as regards to the capabilities and the products of each main company and its supply chain relationships. The action should also support conducting stress tests of the supply chain and develop risk analysis of the EU semiconductor supply chain. Finally, the action needs to support issuing early warnings and recommendations for proactive measures to the Commission and Member States to avoid any potential…

Expected Outcome: The expected outcomes of this topic are : Functional demonstrators of working AI chip prototypes (PCB-level) designed by EU fabless companies and physically integrated with their system partners. Validation of AI chip solutions on a common EU evaluation platform (provided by the Topic X.B consortium), delivering comparative evidence on key performance indicators. A shortlist of European AI chip solutions awarded the AI Compute Excellence label and qualified to proceed to full rack development under Topic X.A2.

Expected Outcome: Project results are expected to contribute to all of the following expected outcomes: Increased understanding of European policy makers, research community, biotech companies, and relevant security practitioners of the threat of bioterrorism and of synthetic biology, including a thorough lawful analysis of what needs to be monitored in this context, what needs to be regulated and how; Awareness raised within the related scientific community how research in synthetic biology can be used for malicious purposes. Scope: The rising threat of bioterrorism is driven by recent scientific advancements, notably by growing accessibility of synthetic biology, genetic engineering, related commercial services and public databases, which in turn enhance their obtainability to non-state actors and individuals with malicious intentions. The proliferation of do-it-yourself biohacking and community laboratories, including gene editing and sequencing technology, dropping costs of equipment and increased simplicity of use may inadvertently facilitate knowledge and skills dissemination about biological threats and open new pathways for bioterrorism. Challenges in detection,…

Expected Impact: In the long-term , the funding is expected to: have increased operational capacity of law enforcement and other security-oriented authorities to fight organised crime and drug production and trafficking, including an improved capability to trace and untangle complex money laundering schemes as well as illicit flows of goods. enhance risk assessments and risk awareness and resilience measures in view of anticipating, preventing and tackling organised crime and drug related crimes. have improved cross-border cooperation including with key third countries and information exchange (including where possible and applicable with the private sector) and sharing of challenges and good practices in fighting against organised crime. have improved detection, identification and referral of victims of crime in the context of cross-border operational actions, as well as improved protection of victims in criminal proceedings, in cooperation with civil society organisations. Expected Outcome: Projects should aim to achieve one or more of the following outcomes: increase understanding of the nature and modus operandi of criminal networks and key actors and enablers including in…

Expected Impact: FOR ALL THREE THEMATIC PRIORITIES: Expected impact at the closure of the project (non-exhaustive list): Innovative technologies tested and adopted by the market; Innovative solutions deployed improving businesses confidence, competences and means to digitalise and grow; Contribution to digitisation and health systems transformation, through various types of innovation and the supply of IT services; Uptake of technologically/economically reliable and viable solutions on the market; Deployment of new technologies fostering the growth of Europe’s manufacturing sector; Innovative technologies adopted by SMEs; Identification of possible sources of funding/funding mix, to cover the residual investment needs (public-private partnerships for the deployment of innovation, the collaboration with venture capitals, EIB group loans etc); Strengthening innovation diffusion channels; Reinforcing the capacity of regions to co-invest together, joining forces on common S3 investment priorities (interregional investments). Long-term impact (non-exhaustive list): Increased companies’ productivity and efficiency; Improved user-friendly, accessible and interoperable public…